Dinopol, Shaniah Kate .
HRN: 26-10-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/21/2024
10/28/2024
IV
400
Q6h
BFS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes